Monetary Management Group Inc Regeneron Pharmaceuticals, Inc. Transaction History

Monetary Management Group Inc

$433 Million
Q3 2025

A detailed history of Monetary Management Group Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Monetary Management Group Inc holds 847 shares of REGN stock, worth $587,394. This represents 0.11% of its overall portfolio holdings.

Number of Shares

847

Previous 1,047 19.1%

Holding current value

$587,394

Previous $549,000 13.3%

% of portfolio

0.11%

Previous 0.14%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$534.91 - $598.71 $106,982 - $119,742	-200 Reduced 19.1%	847 $476,000
Q2 2025 Aug 14, 2025	SELL	$483.07 - $625.6 $28,984 - $37,536	-60 Reduced 5.42%	1,047 $549,000
Q1 2025 May 14, 2025	SELL	$634.14 - $744.83 $431,215 - $506,484	-680 Reduced 38.05%	1,107 $702,000
Q4 2024 Feb 13, 2025	BUY	$701.85 - $1046.91 $147,388 - $219,851	210 Added 13.32%	1,787 $1.27 Million
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $102,408 - $120,176	100 Added 6.77%	1,577 $1.66 Million

Q2 2024 Jul 16, 2024	BUY	$883.2 - $1071.19 $70,656 - $85,695	80 Added 5.73%	1,477 $1.55 Million
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $189,564 - $208,603	210 Added 17.69%	1,397 $1.34 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $71,316 - $81,116	92 Added 8.4%	1,187 $1.04 Million
Q3 2023 Nov 09, 2023	BUY	$692.45 - $844.37 $34,622 - $42,218	50 Added 4.78%	1,095 $901,000
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $140,006 - $166,070	-200 Reduced 16.06%	1,045 $750,000
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $29,756 - $34,921	-50 Reduced 3.86%	1,245 $870,000
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $839,676 - $1.04 Million	-1,545 Reduced 54.4%	1,295 $818,000
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $872,525 - $1.04 Million	1,520 Added 115.15%	2,840 $1.72 Million
Q2 2021 Aug 12, 2021	BUY	$472.8 - $558.54 $624,096 - $737,272	1,320 New	1,320 $737,000

Others Institutions Holding REGN

# of Institutions

1,478

Shares Held

86.4M

Call Options Held

2.38M

Put Options Held

1.61M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Monetary Management Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Monetary Management Group Inc with notifications on news.

Account

Monetary Management Group Inc Regeneron Pharmaceuticals, Inc. Transaction History